Daniel E. Dosoretz

3.9k total citations · 1 hit paper
74 papers, 3.0k citations indexed

About

Daniel E. Dosoretz is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Daniel E. Dosoretz has authored 74 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 19 papers in Oncology. Recurrent topics in Daniel E. Dosoretz's work include Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (24 papers) and Colorectal and Anal Carcinomas (10 papers). Daniel E. Dosoretz is often cited by papers focused on Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (24 papers) and Colorectal and Anal Carcinomas (10 papers). Daniel E. Dosoretz collaborates with scholars based in United States. Daniel E. Dosoretz's co-authors include Rita M. Linggood, Robert L. Martuza, Robert G. Ojemann, R.O. Mirimanoff, Peter H. Blitzer, Sharon Salenius, Michael J. Katin, William U. Shipley, C. C. Wang and James H. Rubenstein and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of neurosurgery.

In The Last Decade

Daniel E. Dosoretz

71 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meningioma: analysis of recurrence and progression following neurosurgical resection

1985 837 citations Daniel E. Dosoretz et al. profile →

Peers

Countries citing papers authored by Daniel E. Dosoretz

Since Specialization

Citations

This map shows the geographic impact of Daniel E. Dosoretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Dosoretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Dosoretz more than expected).

Fields of papers citing papers by Daniel E. Dosoretz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Dosoretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Dosoretz. The network helps show where Daniel E. Dosoretz may publish in the future.

Co-authorship network of co-authors of Daniel E. Dosoretz

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Dosoretz. A scholar is included among the top collaborators of Daniel E. Dosoretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Dosoretz. Daniel E. Dosoretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk 2015 ·Clinical Genitourinary Cancer ·Lior Z. Braunstein, Ming‐Hui Chen, Daniel E. Dosoretz, Sharon Salenius, Michael J. Katin, Akash Nanda, Anthony V. D’Amico	4
2	Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer 2013 ·Brachytherapy ·Arti Parekh, Ming‐Hui Chen, Anthony V. D’Amico, Daniel E. Dosoretz, Rudi Ross, Sharon Salenius, Powell L. Graham, Joshua A. Beckman, Clair J. Beard, Toni K. Choueiri, Ronald D. Ennis, Karen E. Hoffman, Jim C. Hu, Jing Ma, Neil E. Martin, Paul L. Nguyen	4
3	In Vivo Verification as a Tool to Tailor Daily IGRT and Flag Adaptive Radiotherapy 2013 ·Practical Radiation Oncology ·G Olivera, Weiguo Lu, (unknown), X. H. Mo, (unknown), C.A. Mantz, Eduardo B. Fernández, Daniel E. Dosoretz, (unknown), (unknown)	1
4	The Number of High-Risk Factors and the Risk of Prostate Cancer–Specific Mortality After Brachytherapy: Implications for Treatment Selection 2012 ·International Journal of Radiation OncologyBiologyPhysics ·Daniel A. Wattson, Ming‐Hui Chen, Judd W. Moul, Brian J. Moran, Daniel E. Dosoretz, Cary N. Robertson, Thomas J. Polascik, Michelle H. Braccioforte, Sharon Salenius, Anthony V. D’Amico	17
5	Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer 2011 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Ming‐Hui Chen, Yuanye Zhang, Brian J. Moran, Daniel E. Dosoretz, Michael J. Katin, Michelle H. Braccioforte, Sharon Salenius, Anthony V. D’Amico	23
6	Race and Survival Following Brachytherapy-Based Treatment for Men With Localized or Locally Advanced Adenocarcinoma of the Prostate 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Karen M. Winkfield, Ming‐Hui Chen, Daniel E. Dosoretz, Sharon Salenius, Michael J. Katin, Rudi Ross, Anthony V. D’Amico	9
7	Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Paul L. Nguyen, Ming‐Hui Chen, Joshua A. Beckman, Clair J. Beard, Neil E. Martin, Toni K. Choueiri, Jim C. Hu, Karen E. Hoffman, Daniel E. Dosoretz, Brian J. Moran, Sharon Salenius, Michelle H. Braccioforte, Philip W. Kantoff, Anthony V. D’Amico, Ronald D. Ennis	55
8	Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy 2010 ·Cancer ·(unknown), Ming‐Hui Chen, Sharon Salenius, (unknown), Daniel E. Dosoretz, Michael J. Katin, C.A. Mantz, Bruce M. Nakfoor, Anthony V. D’Amico	17
9	Risk of All-Cause and Prostate Cancer–Specific Mortality After Brachytherapy in Men With Small Prostate Size 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Paul L. Nguyen, Ming H. Chen, Toni K. Choueiri, Karen E. Hoffman, Jim C. Hu, Neil E. Martin, Clair J. Beard, Daniel E. Dosoretz, Brian J. Moran, Michael J. Katin, Michelle H. Braccioforte, Rudi Ross, Sharon Salenius, Philip W. Kantoff, Anthony V. D’Amico	8
10	Androgen‐suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke 2010 ·British Journal of Urology ·Julia H. Hayes, Ming‐Hui Chen, Brian J. Moran, Michelle H. Braccioforte, Daniel E. Dosoretz, Sharon Salenius, Michael J. Katin, Rudi Ross, Toni K. Choueiri, Anthony V. D’Amico	19
11	Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation 2010 ·Cancer ·Paul L. Nguyen, Ming H. Chen, Samuel Z. Goldhaber, Neil E. Martin, Clair J. Beard, Daniel E. Dosoretz, Michael J. Katin, Rudi Ross, Sharon Salenius, Anthony V. D’Amico	21
12	Prostate cancer‐specific mortality and the extent of therapy in healthy elderly men with high‐risk prostate cancer 2010 ·Cancer ·Karen E. Hoffman, Ming‐Hui Chen, Brian J. Moran, Michelle H. Braccioforte, Daniel E. Dosoretz, Sharon Salenius, Michael J. Katin, Rudi Ross, Anthony V. D’Amico	28
13	The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement 2010 ·Brachytherapy ·Arthur Cheung, Ming‐Hui Chen, Brian J. Moran, Michelle H. Braccioforte, Daniel E. Dosoretz, Sharon Salenius, Michael J. Katin, Rudi Ross, Anthony V. D’Amico	3
14	Predictors of Prostate Cancer–Specific Mortality in Elderly Men With Intermediate-Risk Prostate Cancer Treated With Brachytherapy With or Without External Beam Radiation Therapy 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Akash Nanda, Ming‐Hui Chen, Brian J. Moran, Michelle H. Braccioforte, Daniel E. Dosoretz, Sharon Salenius, Michael J. Katin, Rudi Ross, Anthony V. D’Amico	11
15	Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis 2004 ·Brachytherapy ·C.A. Mantz, Daniel E. Dosoretz, James H. Rubenstein, Peter H. Blitzer, Michael J. Katin, Graciela R. Garton, Bruce M. Nakfoor, (unknown), Kenneth Tolep, Stephen E. Hannan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	11
16	Small-Cell Lung Carcinoma 1998 ·American Journal of Clinical Oncology ·Daniel E. Dosoretz, James H. Rubenstein, Michael J. Katin, Peter H. Blitzer, Susan A. Reisinger, Graciela R. Garton, Sharon Salenius, (unknown), (unknown), (unknown), James A. Reeves, Mark S. Rubin, Lowell L. Hart, Michael McCleod, (unknown), (unknown)	3
17	Small Cell Anaplastic Carcinoma of the Prostate: Seven New Cases, Review of the Literature, and Discussion of a Therapeutic Strategy 1997 ·American Journal of Clinical Oncology ·James H. Rubenstein, Michael J. Katin, (unknown), (unknown), Sharon Salenius, Daniel E. Dosoretz, Peter H. Blitzer	61
18	Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung 1995 ·International Journal of Radiation OncologyBiologyPhysics ·James H. Rubenstein, Daniel E. Dosoretz, Michael J. Katin, Peter H. Blitzer, Sharon Salenius, (unknown), William N. Harwin, (unknown), (unknown), James A. Reeves, Lowell L. Hart, Michael McCleod, (unknown), (unknown), (unknown)	16
19	Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication 1993 ·International Journal of Radiation OncologyBiologyPhysics ·Daniel E. Dosoretz, (unknown), James H. Rubenstein, Michael J. Katin, Peter H. Blitzer, Sharon Salenius, (unknown), Mohammad H. Rashid, (unknown), Stephen E. Hannan, (unknown), (unknown), (unknown), (unknown), Michael P. Metke	110
20	Radiation therapy in the management of medically inoperable carcinoma of the lungs: Results and implications for future treatment strategies 1992 ·International Journal of Radiation OncologyBiologyPhysics ·Daniel E. Dosoretz, Michael J. Katin, Peter H. Blitzer, James H. Rubenstein, Sharon Salenius, Mohammad H. Rashid, (unknown), (unknown), (unknown), (unknown), (unknown), Stephen E. Hannan, (unknown), Michael P. Metke	191

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact